Literature DB >> 16180049

Establishment of immortalized Schwann cells from Sandhoff mice and corrective effect of recombinant human beta-hexosaminidase A on the accumulated GM2 ganglioside.

Mai Ohsawa1,2, Masaharu Kotani1,2, Youichi Tajima1,2, Daisuke Tsuji1,3, Yasuhiro Ishibashi1,3, Aya Kuroki1,3, Kohji Itoh1,3, Kazuhiko Watabe1,4, Kazunori Sango5, Shoji Yamanaka6, Hitoshi Sakuraba7,8.   

Abstract

We have established spontaneously immortalized Schwann cell lines from dorsal root ganglia and peripheral nerves of Sandhoff mice. One of the cell lines exhibited genetically and biochemically distinct features of Sandhoff Schwann cells. The enzyme activities toward 4-methylumbelliferyl N-acetyl-beta-D-glucosamine (beta-hexosaminidases A, B, and S) and 4-methylumbelliferyl N-acetyl-beta-D-glucosamine-6-sulfate (beta-hexosaminidases A and S) were decreased, and GM2 ganglioside accumulated in lysosomes of the cells. Incorporation of recombinant human beta-hexosaminidase isozymes expressed in Chinese hamster ovary cells into the cultured Sandhoff Schwann cells via cation-independent mannose 6-phosphate receptors was found, and the incorporated beta-hexosaminidase A degraded the accumulated GM2 ganglioside. The established Sandhoff Schwann cell line is useful for investigation and development of therapies for Sandhoff disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16180049     DOI: 10.1007/s10038-005-0278-0

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  21 in total

1.  Establishment and characterization of immortalized Schwann cells from murine model of Niemann-Pick disease type C (spm/spm).

Authors:  K Watabe; H Ida; K Uehara; K Oyanagi; T Sakamoto; J Tanaka; W S Garver; S Miyawaki; K Ohno; Y Eto
Journal:  J Peripher Nerv Syst       Date:  2001-06       Impact factor: 3.494

2.  Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.

Authors:  C M Eng; N Guffon; W R Wilcox; D P Germain; P Lee; S Waldek; L Caplan; G E Linthorst; R J Desnick
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

3.  Lysosomal storage results in impaired survival but normal neurite outgrowth in dorsal root ganglion neurones from a mouse model of Sandhoff disease.

Authors:  K Sango; S Yamanaka; K Ajiki; A Tokashiki; K Watabe
Journal:  Neuropathol Appl Neurobiol       Date:  2002-02       Impact factor: 8.090

4.  Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study.

Authors:  L Klinge; V Straub; U Neudorf; T Voit
Journal:  Neuropediatrics       Date:  2005-02       Impact factor: 1.947

5.  Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides.

Authors:  M Kotani; H Ozawa; I Kawashima; S Ando; T Tai
Journal:  Biochim Biophys Acta       Date:  1992-07-21

Review 6.  Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report.

Authors:  J Muenzer; J C Lamsa; A Garcia; J Dacosta; J Garcia; D A Treco
Journal:  Acta Paediatr Suppl       Date:  2002

7.  Tissue culture methods to study neurological disorders: establishment of immortalized Schwann cells from murine disease models.

Authors:  Kazuhiko Watabe; Tsuyoshi Sakamoto; Yoko Kawazoe; Makoto Michikawa; Katsuichi Miyamoto; Takashi Yamamura; Hideyuki Saya; Norie Araki
Journal:  Neuropathology       Date:  2003-03       Impact factor: 1.906

8.  Mitogenic effects of platelet-derived growth factor, fibroblast growth factor, transforming growth factor-beta, and heparin-binding serum factor for adult mouse Schwann cells.

Authors:  K Watabe; T Fukuda; J Tanaka; K Toyohara; O Sakai
Journal:  J Neurosci Res       Date:  1994-12-01       Impact factor: 4.164

9.  Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.

Authors:  D Phaneuf; N Wakamatsu; J Q Huang; A Borowski; A C Peterson; S R Fortunato; G Ritter; S A Igdoura; C R Morales; G Benoit; B R Akerman; D Leclerc; N Hanai; J D Marth; J M Trasler; R A Gravel
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

10.  Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities.

Authors:  K Watabe; T Fukuda; J Tanaka; H Honda; K Toyohara; O Sakai
Journal:  J Neurosci Res       Date:  1995-06-01       Impact factor: 4.164

View more
  8 in total

Review 1.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

2.  Corrective effect on Fabry mice of yeast recombinant human alpha-galactosidase with N-linked sugar chains suitable for lysosomal delivery.

Authors:  Hitoshi Sakuraba; Yasunori Chiba; Masaharu Kotani; Ikuo Kawashima; Mai Ohsawa; Youichi Tajima; Yuki Takaoka; Yoshifumi Jigami; Hiroshi Takahashi; Yukihiko Hirai; Takashi Shimada; Yasuhiro Hashimoto; Kumiko Ishii; Toshihide Kobayashi; Kazuhiko Watabe; Tomoko Fukushige; Tamotsu Kanzaki
Journal:  J Hum Genet       Date:  2006-03-11       Impact factor: 3.172

3.  Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta.

Authors:  Hiromi Akeboshi; Yasunori Chiba; Yoshiko Kasahara; Minako Takashiba; Yuki Takaoka; Mai Ohsawa; Youichi Tajima; Ikuo Kawashima; Daisuke Tsuji; Kohji Itoh; Hitoshi Sakuraba; Yoshifumi Jigami
Journal:  Appl Environ Microbiol       Date:  2007-06-08       Impact factor: 4.792

Review 4.  Immortalized adult rodent Schwann cells as in vitro models to study diabetic neuropathy.

Authors:  Kazunori Sango; Hiroko Yanagisawa; Shizuka Takaku; Emiko Kawakami; Kazuhiko Watabe
Journal:  Exp Diabetes Res       Date:  2011-06-13

Review 5.  Glial cell lines: an overview.

Authors:  George H De Vries; Anne I Boullerne
Journal:  Neurochem Res       Date:  2010-12-03       Impact factor: 3.996

6.  Peripheral nervous system manifestations in a Sandhoff disease mouse model: nerve conduction, myelin structure, lipid analysis.

Authors:  Melanie A McNally; Rena C Baek; Robin L Avila; Thomas N Seyfried; Gary R Strichartz; Daniel A Kirschner
Journal:  J Negat Results Biomed       Date:  2007-07-10

7.  Human recombinant lysosomal β-Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay-Sachs fibroblasts.

Authors:  Angela J Espejo-Mojica; Alexander Rodríguez-López; Rong Li; Wei Zheng; Carlos J Alméciga-Díaz; Cindy Dulcey-Sepúlveda; Germán Combariza; Luis A Barrera
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-10-27       Impact factor: 3.359

8.  Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease.

Authors:  Mylinh Vu; Rong Li; Amanda Baskfield; Billy Lu; Atena Farkhondeh; Kirill Gorshkov; Omid Motabar; Jeanette Beers; Guokai Chen; Jizhong Zou; Angela J Espejo-Mojica; Alexander Rodríguez-López; Carlos J Alméciga-Díaz; Luis A Barrera; Xuntian Jiang; Daniel S Ory; Juan J Marugan; Wei Zheng
Journal:  Orphanet J Rare Dis       Date:  2018-09-17       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.